Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s372, 2024. DOI: 10.25251/skin.8.supp.372. Disponível em: https://skin.dermsquared.com/skin/article/view/2590. Acesso em: 15 may. 2025.